BioSpace News Archive

Business

Nuvalent Highlights Pipeline and Business Progress and Reports First Quarter 2022 Financial Results

Nuvalent, Inc., a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, reported pipeline and business progress and first quarter 2022 financial results.

May 12, 2022
·
8 min read
Business

Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, reported financial results for the quarter ended March 31, 2022.

May 12, 2022
·
11 min read
Business

RVL Pharmaceuticals plc Reports First Quarter 2022 Financial Results; Provides Commercial Update

RVL Pharmaceuticals plc, a specialty pharmaceutical company, announced financial results and business highlights for the three months ended March 31, 2022.

May 12, 2022
·
18 min read
Pharm Country

BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.

BD, a leading global medical technology company, announced the U.S. launch of its new, fully automated, high-throughput infectious disease molecular diagnostics platform.

May 12, 2022
·
4 min read
Biotech Beach

Hygieia Launches d-Nav® Clinical Partnership Program at AACE Annual Meeting

Hygieia, a digital therapeutics company, announced the official launch of its d-Nav Clinical Partnership Program for endocrinology practices treating patients with type 2 diabetes.

May 12, 2022
·
3 min read
Biotech Bay

Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

Lucira Health, Inc., a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced that it has submitted a request to the U.S. Food and Drug Administration for emergency use authorization for its COVID-19 & Flu test.

May 12, 2022
·
5 min read
Business

Ikena Oncology Reports First Quarter 2022 Financial Results and Provides a Corporate Update

Ikena Oncology, Inc., a targeted oncology company forging new territory in patient-directed cancer treatment, announced financial results for the first quarter ended March 31, 2022.

May 12, 2022
·
9 min read
Business

Orchard Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Commercial Progress

Orchard Therapeutics, a global gene therapy leader, announced recent business highlights along with its financial results for the quarter ended March 31, 2022.

May 12, 2022
·
18 min read
Drug Development

MediWound Announces Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds

MediWound Ltd. announced positive results from its U.S. Phase 2 clinical study of EscharEx® for the debridement of venous leg ulcers.

May 12, 2022
·
14 min read
Business

Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patients with autoimmune diseases, today reported financial results for the first quarter ended March 31, 2022, and provided a business update.

May 12, 2022
·
12 min read